nasdaq:stml
|
8501716
|
Apr 14th, 2024 12:00AM
|
Menarini Stemline
|
27K
|
501.00
|
Open
|
|
Apr 13th, 2024 11:45PM
|
Apr 13th, 2024 11:45PM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Apr 13th, 2024 12:00AM
|
Menarini Stemline
|
27K
|
502.00
|
Open
|
|
Apr 13th, 2024 12:10PM
|
Apr 13th, 2024 12:10PM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Apr 12th, 2024 12:00AM
|
Menarini Stemline
|
27K
|
498.00
|
Open
|
|
Apr 12th, 2024 09:06AM
|
Apr 12th, 2024 09:06AM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Apr 11th, 2024 12:00AM
|
Menarini Stemline
|
27K
|
497.00
|
Open
|
|
Apr 11th, 2024 12:25AM
|
Apr 11th, 2024 12:25AM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Apr 9th, 2024 12:00AM
|
Menarini Stemline
|
27K
|
498.00
|
Open
|
|
Apr 8th, 2024 11:55PM
|
Apr 9th, 2024 10:40AM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Apr 3rd, 2024 12:00AM
|
Menarini Stemline
|
27K
|
497.00
|
Open
|
|
Apr 3rd, 2024 10:37AM
|
Apr 3rd, 2024 10:37AM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Apr 2nd, 2024 12:00AM
|
Menarini Stemline
|
27K
|
496.00
|
Open
|
|
Apr 2nd, 2024 12:33AM
|
Apr 2nd, 2024 12:33AM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Mar 31st, 2024 12:00AM
|
Menarini Stemline
|
27K
|
496.00
|
Open
|
|
Mar 31st, 2024 02:03PM
|
Mar 31st, 2024 02:03PM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Mar 30th, 2024 12:00AM
|
Menarini Stemline
|
26K
|
496.00
|
Open
|
|
Mar 30th, 2024 01:05AM
|
Mar 30th, 2024 01:05AM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|
nasdaq:stml
|
8501716
|
Mar 28th, 2024 12:00AM
|
Menarini Stemline
|
26K
|
496.00
|
Open
|
|
Mar 28th, 2024 12:14PM
|
Mar 28th, 2024 12:14PM
|
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer.
Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer.
Netiquette & Privacy Notice: https://bit.ly/48X6JSN
|
Open
|
|
Open
|
750 Lexington Avenue
|
New York
|
New York
|
US
|
10022
|
|
Stemline Therapeutics
|
|
Health Care Equipment & Services
|